Uridine Monophosphate : Neurotransmitter Imbalance
C エビデンス 小規模研究からのエビデンスは限られていますが、いくつかの肯定的なシグナルがあります。The uridine + DHA + choline combination (known as the 'Mr. Happy Stack') provides synergistic support for phospholipid synthesis and dopamine receptor expression. Limited but promising clinical evidence.
結論
The uridine + DHA + choline combination (known as the 'Mr. Happy Stack') provides synergistic support for phospholipid synthesis and dopamine receptor expression. Limited but promising clinical evidence.
Key Study Findings
対象集団: LPS-induced inflammatory astrocyte model
対象集団: Dogs with intervertebral disc herniation
対象集団: None
対象集団: Sprague Dawley rats
対象集団: Healthy adults
対象集団: Mild cognitive impairment and some other neurological diseases
Key Statistics
4
研究数
300
参加者数
Positive
グレード
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
一般的な使用量
- general:
- 150-250 mg/day
- cognitivesupport:
- 250-500 mg sublingually
上限量: Not established; well-tolerated up to 1,000 mg/day
研究で検討された用量
| 用量 | 期間 | 効果 | N |
|---|---|---|---|
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Mixed | -- |
| 5 mg/kg | 4 weeks | Positive | -- |
| None | -- | Neutral | -- |
| None | -- | Mixed | -- |
| 1 g | -- | Mixed | -- |
| None | -- | Mixed | -- |
推奨摂取タイミング: Morning; synergizes with DHA and choline sources
Safety & Side Effects
報告されている副作用
- ⚠ Mild gastrointestinal discomfort
- ⚠ Headache (rare)
- ⚠ Nervousness at high doses
既知の相互作用
- ● No significant drug interactions established
耐容上限摂取量: Not established; well-tolerated up to 1,000 mg/day
サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。
Frequently Asked Questions
Does Uridine Monophosphate help with Neurotransmitter Imbalance?
How much Uridine Monophosphate should I take for Neurotransmitter Imbalance?
Are there side effects of Uridine Monophosphate?
How strong is the evidence for Uridine Monophosphate and Neurotransmitter Imbalance?
Related Evidence
に関する他の成分: Neurotransmitter Imbalance
References
- [1] Anita Horvatić et al.. Metabolites. 2025. Combining Metabolomics and Proteomics to Reveal Key Serum Compounds Related to Canine Intervertebral Disc Herniation. doi:10.3390/metabo15060396 PubMed
- [2] Jingxuan Ma et al.. Nutrients. 2025. The Effects of Semen Ziziphi Spinosae Extract on LPS-Induced Astrocyte Gene Expression and Metabolites. doi:10.3390/nu17223498 PubMed
- [3] Birnur Aydin et al.. Pharmacol Rep. 2025. Involvement of uridine in brain and gut health: insights into its neuroprotective potential via the gut-brain axis. doi:10.1007/s43440-025-00788-5 PubMed
- [4] Ziyan Zhong et al.. Drug Des Devel Ther. 2024. Jujuboside A Regulates Calcium Homeostasis and Structural Plasticity to Alleviate Depression-Like Behavior via Shh Signaling in Immature Neurons. doi:10.2147/DDDT.S479055 PubMed
- [5] Kimberly L Chan et al.. Brain Commun. 2024. 1H and 31P magnetic resonance spectroscopy reveals potential pathogenic and biomarker metabolite alterations in Lafora disease. doi:10.1093/braincomms/fcae104 PubMed
- [6] Lanmei Wang et al.. Int J Mol Sci. 2023. Integrated Analysis of Transcriptomics and Metabolomics Unveil the Novel Insight of One-Year-Old Precocious Mechanism in the Chinese Mitten Crab, Eriocheir … doi:10.3390/ijms241311171 PubMed
- [7] Maciej Świątkiewicz et al.. Aging Dis. 2023. Citicoline for Supporting Memory in Aging Humans. doi:10.14336/AD.2022.0913 PubMed
- [8] Caley A Hogan et al.. EMBO Rep. 2023. Expanded tRNA methyltransferase family member TRMT9B regulates synaptic growth and function. doi:10.15252/embr.202356808 PubMed
- [9] Sreyashi Samaddar et al.. Int J Mol Sci. 2022. The G Protein-Coupled Serotonin 1A Receptor Augments Protein Kinase Cε-Mediated Neurogenesis in Neonatal Mouse Hippocampus-PKCε-Mediated Signaling in the Early Hippocampus. doi:10.3390/ijms23041962 PubMed
- [10] Pengtao Xu et al.. Neurochem Int. 2021. Region-specific metabolic characterization of the type 1 diabetic brain in mice with and without cognitive impairment. doi:10.1016/j.neuint.2020.104941 PubMed
- [11] Charles Kennedy. Auton Neurosci. 2021. ATP as a cotransmitter in sympathetic and parasympathetic nerves - another Burnstock legacy. doi:10.1016/j.autneu.2021.102860 PubMed
- [12] Lina A Dahabiyeh et al.. Metabolites. 2020. Dexamethasone-Induced Perturbations in Tissue Metabolomics Revealed by Chemical Isotope Labeling LC-MS analysis. doi:10.3390/metabo10020042 PubMed
- [13] Grace Chen et al.. Clin Pharmacokinet. 2018. Vortioxetine: Clinical Pharmacokinetics and Drug Interactions. doi:10.1007/s40262-017-0612-7 PubMed
- [14] Leonie Durnin et al.. Am J Physiol Gastrointest Liver Physiol. 2017. Loss of nitric oxide-mediated inhibition of purine neurotransmitter release in the colon in the absence of interstitial cells of Cajal. doi:10.1152/ajpgi.00045.2017 PubMed
- [15] Richard J Wurtman. Eur J Pharmacol. 2017. Synapse formation in the brain can be enhanced by co-administering three specific nutrients. doi:10.1016/j.ejphar.2017.09.038 PubMed
- [16] Zacharias Kohl et al.. Neurobiol Dis. 2016. Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC α-synuclein transgenic rat model of Parkinson's disease. doi:10.1016/j.nbd.2015.10.021 PubMed
- [17] Vera Ralevic et al.. Auton Neurosci. 2015. Purinergic transmission in blood vessels. doi:10.1016/j.autneu.2015.04.007 PubMed
- [18] Tushar K Bhattacharya et al.. Physiol Behav. 2015. Exercise but not (-)-epigallocatechin-3-gallate or β-alanine enhances physical fitness, brain plasticity, and behavioral performance in mice. doi:10.1016/j.physbeh.2015.03.023 PubMed
- [19] Morag J Andrew et al.. BMC Pediatr. 2015. Optimising nutrition to improve growth and reduce neurodisabilities in neonates at risk of neurological impairment, and children with suspected or … doi:10.1186/s12887-015-0339-2 PubMed
- [20] Ove Lundgren et al.. PLoS One. 2011. Intestinal epithelial stem/progenitor cells are controlled by mucosal afferent nerves. doi:10.1371/journal.pone.0016295 PubMed
- [21] Richard J Wurtman. Eur J Pharmacol. 2011. Non-nutritional uses of nutrients. doi:10.1016/j.ejphar.2011.07.005 PubMed
- [22] Weigang Gu et al.. Stem Cell Res. 2010. Neurotransmitter synthesis in poststroke cortical neurogenesis in adult rats. doi:10.1016/j.scr.2009.12.001 PubMed
- [23] Beate Winner et al.. Exp Neurol. 2009. Dopamine receptor activation promotes adult neurogenesis in an acute Parkinson model. doi:10.1016/j.expneurol.2009.07.013 PubMed
- [24] Richard J Wurtman et al.. Annu Rev Nutr. 2009. Use of phosphatide precursors to promote synaptogenesis. doi:10.1146/annurev-nutr-080508-141059 PubMed
- [25] Mehmet Cansev et al.. Alzheimers Dement. 2008. Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses. doi:10.1016/j.jalz.2007.10.005 PubMed
- [26] Sarah Holguin et al.. FASEB J. 2008. Dietary uridine enhances the improvement in learning and memory produced by administering DHA to gerbils. doi:10.1096/fj.08-112425 PubMed
- [27] Anayansi Molina-Hernández et al.. J Neurochem. 2008. Histamine induces neural stem cell proliferation and neuronal differentiation by activation of distinct histamine receptors. doi:10.1111/j.1471-4159.2008.05424.x PubMed
- [28] Myung-Min Choi et al.. Biotechnol Appl Biochem. 2008. Small-interfering-RNA-mediated silencing of human glutamate dehydrogenase induces apoptosis in neuroblastoma cells. doi:10.1042/BA20070190 PubMed
- [29] Sophie Scotto-Lomassese et al.. Eur J Neurosci. 2007. HVC interneurons are not renewed in adult male zebra finches. doi:10.1111/j.1460-9568.2007.05418.x PubMed
- [30] Keely M Bumsted-O'Brien et al.. J Comp Neurol. 2007. Expression of the homeodomain transcription factor Meis2 in the embryonic and postnatal retina. doi:10.1002/cne.21458 PubMed
- [31] Lei Wang et al.. J Mol Neurosci. 2005. Dietary uridine-5'-monophosphate supplementation increases potassium-evoked dopamine release and promotes neurite outgrowth in aged rats. doi:10.1385/JMN:27:1:137 PubMed
- [32] Laszlo Köles et al.. Drug News Perspect. 2005. P2X and P2Y receptors as possible targets of therapeutic manipulations in CNS illnesses. doi:10.1358/dnp.2005.18.2.886479 PubMed
- [33] Marisa L Kreider et al.. Neuropsychopharmacology. 2005. Disruption of rat forebrain development by glucocorticoids: critical perinatal periods for effects on neural cell acquisition and on cell signaling … doi:10.1038/sj.npp.1300743 PubMed
- [34] H Jørgensen et al.. J Neuroendocrinol. 2002. Serotonergic stimulation of corticotropin-releasing hormone and pro-opiomelanocortin gene expression. doi:10.1046/j.1365-2826.2002.00839.x PubMed
- [35] A Martínez-Contreras et al.. J Neurosci Res. 2002. Astrocytic and microglia cells reactivity induced by neonatal administration of glutamate in cerebral cortex of the adult rats. doi:10.1002/jnr.10093 PubMed
- [36] Lynette D Fairbanks et al.. Biochem J. 2002. Severe pyridine nucleotide depletion in fibroblasts from Lesch-Nyhan patients. doi:10.1042/BJ20020148 PubMed
- [37] Andrei B Belousov et al.. J Neurophysiol. 2002. Calcium-dependent regulation of cholinergic cell phenotype in the hypothalamus in vitro. doi:10.1152/jn.2002.88.3.1352 PubMed
- [38] Francesco Fornai et al.. Funct Neurol. 2002. Is there a role for uridine and pyrimidine nucleosides in the treatment of vascular dementia? PubMed
- [39] D R Piper et al.. J Neurosci Res. 2001. Identification and characterization of neuronal precursors and their progeny from human fetal tissue. doi:10.1002/jnr.1228 PubMed
- [40] W Mayo et al.. Horm Behav. 2001. Pregnenolone sulfate and aging of cognitive functions: behavioral, neurochemical, and morphological investigations. doi:10.1006/hbeh.2001.1677 PubMed
- [41] L Studer et al.. J Neurosci. 2000. Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. doi:10.1523/JNEUROSCI.20-19-07377.2000 PubMed
- [42] C J Tai et al.. J Clin Endocrinol Metab. 2000. Expression and regulation of P2U-purinergic receptor in human granulosa-luteal cells. doi:10.1210/jcem.85.4.6558 PubMed
- [43] J Kardos et al.. Neuroreport. 1999. Uridine activates fast transmembrane Ca2+ ion fluxes in rat brain homogenates. doi:10.1097/00001756-199905140-00034 PubMed
- [44] W Ma et al.. Microsc Res Tech. 1998. GABA, GAD, and GABA(A) receptor alpha4, beta1, and gamma1 subunits are expressed in the late embryonic and early postnatal neocortical … doi:10.1002/(SICI)1097-0029(19980301)40:5<398::AID-JEMT6>3.0.CO;2-N PubMed
- [45] J J Park et al.. J Neurobiol. 1996. Neurogenesis and cell migration into the sexually dimorphic preoptic area/anterior hypothalamus of the fetal ferret. doi:10.1002/(SICI)1097-4695(199607)30:3<315::AID-NEU1>3.0.CO;2-7 PubMed
- [46] K D Moore et al.. Mol Chem Neuropathol. 1996. In vitro properties of a newly established medulloblastoma cell line, MCD-1. doi:10.1007/BF02814996 PubMed
- [47] S Kentroti et al.. J Neurosci Res. 1996. Ethanol neurotoxicity in culture: selective loss of cholinergic neurons. doi:10.1002/(SICI)1097-4547(19960615)44:6<577::AID-JNR8>3.0.CO;2-8 PubMed
- [48] S Inoué et al.. Behav Brain Res. 1995. Sleep as neuronal detoxification and restitution. doi:10.1016/0166-4328(95)00014-k PubMed
- [49] P J Lein et al.. Dev Biol. 1989. Laminin and a basement membrane extract have different effects on axonal and dendritic outgrowth from embryonic rat sympathetic neurons in … doi:10.1016/0012-1606(89)90260-1 PubMed
- [50] E R de Kloet. J Steroid Biochem. 1984. Adrenal steroids as modulators of nerve cell function. doi:10.1016/0022-4731(84)90204-8 PubMed
- [51] E W Godfrey et al.. Brain Res. 1975. Neurons from fetal rat brain in a new cell culture system: a multidisciplinary analysis. doi:10.1016/0006-8993(75)90679-4 PubMed
FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。